Biology Reference
In-Depth Information
138. Wu H, Lee SH, Gao J, Liu X, Iruela-Arispe
ML (1999) Inactivation of erythropoietin
leads to defects in cardiac morphogenesis.
Development 126:3597-3605
139. Suzuki N, Ohneda O, Takahashi S, Higuchi
M, Mukai HY, Nakahata T, Imagawa S,
Yamamoto M (2002) Erythroid-specific
expression of the erythropoietin receptor res-
cued its null mutant mice from lethality.
Blood 100:2279-2288
140. Stuckmann I, Evans S, Lassar AB (2003)
Erythropoietin and retinoic acid, secreted from
the epicardium, are required for cardiac myo-
cyte proliferation. Dev Biol 255:334-349
141. Hefer D, Yi T, Selby DE, Fishbaugher DE,
Tremble SM, Begin KJ, Gogo P, Lewinter
MM, Meyer M, Palmer BM, Vanburen P
(2012) Erythropoietin induces positive inotro-
pic and lusitropic effects in murine and human
myocardium. J Mol Cell Cardiol 52:256-263
142. Kaygisiz Z, Erkasap N, Yazihan N, Sayar K,
Ataoglu H, Uyar R, Ikizler M (2006)
Erythropoietin changes contractility, cAMP,
and nitrite levels of isolated rat hearts. J Physiol
Sci 56:247-251
143. Hanlon PR, Fu P, Wright GL, Steenbergen C,
Arcasoy MO, Murphy E (2005) Mechanisms
of erythropoietin-mediated cardioprotection
during ischemia-reperfusion injury: role of
protein kinase C and phosphatidylinositol
3-kinase signaling. FASEB J 19:1323-1325
144. Wright GL, Hanlon P, Amin K, Steenbergen
C, Murphy E, Arcasoy MO (2004)
Erythropoietin receptor expression in adult
rat cardiomyocytes is associated with an acute
cardioprotective effect for recombinant eryth-
ropoietin during ischemia-reperfusion injury.
FASEB J 18:1031-1033
145. Salisch S, Klar M, Thurisch B, Bungert J, Dame
C (2011) Gata4 and Sp1 regulate expression
of the erythropoietin receptor in cardiomyo-
cytes. J Cell Mol Med 15:1963-1972
146. Depping R, Kawakami K, Ocker H, Wagner
JM, Heringlake M, Noetzold A, Sievers HH,
Wagner KF (2005) Expression of the erythro-
poietin receptor in human heart. J Thorac
Cardiovasc Surg 130:877-878
147. Mihov D, Bogdanov N, Grenacher B,
Gassmann M, Zund G, Bogdanova A, Tavakoli
R (2009) Erythropoietin protects from reper-
fusion-induced myocardial injury by enhanc-
ing coronary endothelial nitric oxide
production. Eur J Cardiothorac Surg 35:839-
846, discussion 846
148. Parsa CJ, Kim J, Riel RU, Pascal LS,
Thompson RB, Petrofski JA, Matsumoto A,
Stamler JS, Koch WJ (2004) Cardioprotective
effects of erythropoietin in the reperfused
ischemic heart: a potential role for cardiac
fibroblasts. J Biol Chem 279:20655-20662
149. Moon C, Krawczyk M, Paik D, Coleman T,
Brines M, Juhaszova M, Sollott SJ, Lakatta
EG, Talan MI (2006) Erythropoietin,
modified to not stimulate red blood cell pro-
duction, retains its cardioprotective proper-
ties. J Pharmacol Exp Ther 316:999-1005
150. Ahmet I, Tae HJ, Juhaszova M, Riordon DR,
Boheler KR, Sollott SJ, Brines M, Cerami A,
Lakatta EG, Talan MI (2011) A small non-
erythropoietic helix B surface peptide based
upon erythropoietin structure is cardiopro-
tective against ischemic myocardial damage.
Mol Med 17:194-200
151. Chin K, Oda N, Shen K, Noguchi CT (1995)
Regulation of transcription of the human
erythropoietin receptor gene by proteins
binding to GATA-1 and Sp1 motifs. Nucleic
Acids Res 23:3041-3049
152. Kirschner KM, Hagen P, Hussels CS,
Ballmaier M, Scholz H, Dame C (2008) The
Wilms' tumor suppressor Wt1 activates tran-
scription of the erythropoietin receptor in
hematopoietic progenitor cells. FASEB J
22:2690-2701
153. Zhou B, Ma Q, Rajagopal S, Wu SM, Domian
I, Rivera-Feliciano J, Jiang D, von Gise A,
Ikeda S, Chien KR, Pu WT (2008) Epicardial
progenitors contribute to the cardiomyocyte
lineage in the developing heart. Nature
454:109-113
154. Chu CY, Cheng CH, Chen GD, Chen YC,
Hung CC, Huang KY, Huang CJ (2007) The
zebrafish erythropoietin: functional
identification and biochemical characteriza-
tion. FEBS Lett 581:4265-4271
155. Lin JS, Chen YS, Chiang HS, Ma MC (2008)
Hypoxic preconditioning protects rat hearts
against ischaemia-reperfusion injury: role of
erythropoietin on progenitor cell mobiliza-
tion. J Physiol 586:5757-5769
156. Piuhola J, Kerkela R, Keenan JI, Hampton
MB, Richards AM, Pemberton CJ (2008)
Direct cardiac actions of erythropoietin
(EPO): effects on cardiac contractility, BNP
secretion and ischaemia/reperfusion injury.
Clin Sci (Lond) 114:293-304
157. Li Y, Takemura G, Okada H, Miyata S,
Maruyama R, Li L, Higuchi M, Minatoguchi
S, Fujiwara T, Fujiwara H (2006) Reduction
of inflammatory cytokine expression and oxi-
dative damage by erythropoietin in chronic
heart failure. Cardiovasc Res 71:684-694
158. Fu P, Arcasoy MO (2007) Erythropoietin
protects cardiac myocytes against anthracy-
cline-induced apoptosis. Biochem Biophys
Res Commun 354:372-378
Search WWH ::
Custom Search